Article Text

other Versions

Download PDFPDF
The strategic dialogue on tobacco harm reduction: A vision and blueprint for action in the United States
  1. Mitch Zeller1,
  2. Dorothy Hatsukami2,
  3. Cathy Backinger3,
  4. Neal Benowitz4,
  5. Lois Biener5,
  6. David Burns6,
  7. Pamela Clark7,
  8. Greg Connolly8,
  9. Mirjana V. Djordjevic3,
  10. Thomas Eissenberg9,
  11. Gary A. Giovino10,
  12. Cheryl Healton11,
  13. Stephen S. Hecht2,
  14. Jack E Henningfield1,
  15. Corrine Husten12,
  16. Kimberly Kobus13,
  17. Scott Leischow14,
  18. David T. Levy15,
  19. Stephen Marcus16,
  20. Matthew L. Myers17,
  21. Mark Parascandola18,
  22. Prabhu Ponkshe19,
  23. Peter G. Shields20,
  24. Paul Slovic21,
  25. David Sweanor22,
  26. Kenneth E. Warner23
  1. 1 Pinney Associates, United States;
  2. 2 University of Minnesota, United States;
  3. 3 National Cancer Institute, United States;
  4. 4 University of California, San Francisco, United States;
  5. 5 University of Massachusetts Boston, United States;
  6. 6 University of California, San Diego, United States;
  7. 7 Battelle Center for Public Health, Baltimore, MD, United States;
  8. 8 Harvard School of Public Health, Boston, MA, United States;
  9. 9 Virginia Commonwealth University, United States;
  10. 10 University at Buffalo; SUNY, United States;
  11. 11 American Legacy Foundation, United States;
  12. 12 Partnership for Prevention, Washington, D.C., United States;
  13. 13 University of Illinois at Chicago, United States;
  14. 14 The University of Arizona, United States;
  15. 15 Pacific Institute, United States;
  16. 16 National Cancer Institute, Rockville, MD, United States;
  17. 17 Campaign for Tobacco-Free Kids, Washington, DC, United States;
  18. 18 NIH/NCI, United States;
  19. 19 Health Matrix Inc., McLean, VA, United States;
  20. 20 Georgetown University, Washington, DC, United States;
  21. 21 Decision Research, Eugene, OR, United States;
  22. 22 University of Ottawa, Ottawa, Ontario, United States;
  23. 23 University of Michigan, United States
  1. E-mail: mzeller{at}


The issues related to tobacco harm reduction continue to challenge the tobacco control research and policy communities. The potential for combusting tobacco products to reduce exposure and risk remains largely unknown, but this has not stopped manufacturers from offering such products making these claims. The role of oral tobacco products in a harm reduction regimen has also been a source of dialogue and debate. Within the last few years, major cigarette manufacturing companies have begun selling smokeless products for the first time, claiming to target current cigarette smokers. Other cigarette manufacturers are also offering smokeless products in markets around the world. The harm reduction debate has at times been divisive. There has been no unifying set of principles or goals articulated to guide tobacco control efforts. In particular, the research needs are extraordinarily high in order to drive evidence-based policy in this area and avoid the mistakes made with “light” cigarettes. This paper discusses recommendations from a strategic dialogue held with key, mostly U.S.-based tobacco control researchers and policy makers to develop a strategic vision and blueprint for research, policy, and communications to reduce the harm from tobacco for the U.S. Short- and long-term objectives are described.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.